Loading…
Details
- Instance of
- rare disease, type of disease
- Subclass of
- TDP-43 Proteinopathies, frontotemporal degeneration with dementia, genetic neurodegenerative disease with dementia, encephalopathy
- genetic association
- CHMP2B
- has cause
- unknown
- health specialty
- Neurology, psychiatry, and neuropsychiatry
- medical examination
- medical history, neurological diagnostic techniques, magnetic resonance imaging, autopsy
- possible treatment
- selective serotonin reuptake inhibitor, antipsychotics
- prevalence
- 0.00022
- symptoms and signs
- dementia, change, behavioral disorder, anomic aphasia, primary progressive aphasia, language disorder, memory disorder, motor disorder
- topic's main category
- Category:Frontotemporal dementia
Connected on Wikidata
Subject of
- F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
- Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
- Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
- Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
- Stem Cell Transplant for Inborn Errors of Metabolism
- Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- Direct Current Brain Polarization in Frontotemporal Dementia
- Study of Lithium Carbonate to Treat Niemann-Pick Type C1 Disease
- The Swedish BioFINDER 2 Study
- A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
- Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Nothing in the MetaHistoryBook collection references this item yet.